Chemoimmunotherapy: Efficacy Among Small Cell Lung Cancer Patients
“The overall take home message from the Virtual ASCO Annual Meeting this year is that...
Read More
Meeting Coverage
Conference Highlights – AIDS 2020: Virtual – A Focus on COVID-19
New research was presented at AIDS 2020: Virtual, the 23rd International AIDS Conference, from...
Read More
ASCO 2020: Atezolizumab with SABR May Be Feasible for Early State NSCLC
Phase 1 trial shows feasibility and safety of neoadjuvant and adjuvant atezolizumab with...
Read More
Phase III ADAURA Trial: Practice Changing Results for NSCLC
Adjuvant osimertinib demonstrated a statistically significant and clinically meaningful benefit...
Read More
New Immunotherapy Treatment Promising for NSCLC
A new type of immunotherapy treatment for metastatic non-small cell lung cancer (NSCLC) is being...
Read More
CASPIAN Trial Update: Phase 3 Results & Perspectives
Updated findings from the phase 3 CASPIAN trial presented at the 2020 American Society of Clinical...
Read MoreNivolumab and Chemo Significantly Improved Survival in ES-SCL
In the phase 2 ECOG-ACRIN EA5161 trial, a significant improvement in both progression-free and overall survival was observed from adding the checkpoint inhibitor nivolumab to chemotherapy (cisplatin/carboplatin with etoposide)...
Read More
New Second-Line Treatment Option for Malignant Pleural Mesothelioma?
To date, second-line chemotherapy is not the standard of care in patients with malignant pleural...
Read More
Conference Highlights: ADA 2020
New research was presented at ADA 2020, the virtual 80th Scientific Sessions of American Diabetes...
Read More
ASCO: Breast Cancer Brain Mets Treated with Tucatinib
Addition of agent to chemotherapy improves survival The risk of death or progression of brain...
Read More
ASCO: Larotrectinib Produces Durable Responses
TRK fusion targets multiple cancers Patients diagnosed with a variety of advanced cancers —...
Read More
ASCO: Survival Benefit Emerges in ARAMIS
Darolutamide better in non-metastatic castration-resistant prostate cancer Men diagnosed with...
Read More
ASCO: Consultant Palliation Improves AML Quality of Life
Early referral linked to better psychological outcomes Referring a patient diagnosed with acute...
Read More
ASCO: Gastric Cancer Patients Respond to Trastuzumab Deruxtecan
Overall survival also extended with conjugate treatment In a small, phase II trial, patients with...
Read More
Mortality Rate 13% for Cancer Patients with COVID-19
MONDAY, June 1, 2020 (HealthDay News) — For patients with cancer and COVID-19, mortality is...
Read More
ASCO 2020: Relugolix Superior to Leuprolide in Advanced Prostate Cancer
FRIDAY, May 29, 2020 (HealthDay News) — For men with advanced prostate cancer, the oral...
Read More
Conference Highlights: AATS 2020
New research was presented at AATS 2020, the virtual Annual Meeting of the American Association...
Read More
Medical News Forecast for May 25-31
An FDA Covid-19 Town Hall, ASCO’s virtual meeting, upcoming drug approvals, and more Here is...
Read More
ASCO: Virtual Meeting Kicks Off May 29
Three days packed with presentations The American Society of Clinical Oncology is the leading...
Read More
Conference Highlights: Virtual SCAI 2020
New research was presented at SCAI 2020, the virtual Society for Cardiovascular Angiography &...
Read More